IC
EBS icon

IEQ Capital’s Emergent Biosolutions EBS Stock Holding History

IEQ Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$488K Buy
58,252
+6,919
+13% +$57.9K ﹤0.01% 1415
2026
Q1 		$426K Buy
51,333
+19,471
+61% +$202K ﹤0.01% 1372
2025
Q4 		$394K Sell
31,862
-2,446
-7% -$26.2K ﹤0.01% 1432
2025
Q3 		$303K Buy
+34,308
New +$267K ﹤0.01% 1524

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

IEQ Capital's EBS Position: Q2 2026 in Review

IEQ Capital increased its Emergent Biosolutions (EBS) stake by 13% in Q2 2026, buying an estimated $57.9K and bringing the position to 58,252 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

IEQ Capital first reported a position in EBS in Q3 2025 and has held it in 4 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • IEQ Capital held 58,252 shares of Emergent Biosolutions worth $488K as of Q2 2026.
  • IEQ Capital bought 6,919 Emergent Biosolutions shares in Q2 2026, an estimated $57.9K.
  • Emergent Biosolutions made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1415 holding.
  • IEQ Capital first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 4 quarters since.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.